Browse medicines, page 26 of 34

Use listed on the medicine record

To reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Use listed on the medicine record

Functional bowel/irritable bowel syndrome

Use listed on the medicine record

for relief of: bloating pressure fullness stuffed feeling commonly referred to as gas

Use listed on the medicine record

INDICATIONS & USAGE Dipyridamole Injection is indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately. In a study of about 1100 patients who underwent coronary arteriography and Dipyridamole Injection assisted thallium imaging, the results of both tests were interpreted blindly and the sensitivity and specificity of the dipyridamole thallium study in predicting the angiographic outcome were calculated.

Use listed on the medicine record

Acute lymphoblastic leukemia acute myeloblastic leukemia Hodgkin lymphoma non-Hodgkin lymphoma (NHL) metastatic breast cancer metastatic Wil

Use listed on the medicine record

Cluster headache

Use listed on the medicine record

Moderate to severe vasomotor symptoms (VMS) due to menopause

Use listed on the medicine record

Relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by

Use listed on the medicine record

INDICATIONS & USAGE Estazolam is indicated for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Both outpatient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance (see CLINICAL PHARMACOLOGY ). Because insomnia is often transient and intermittent, the prolonged administration of estazolam is generally neither necessary nor recommended.

Use listed on the medicine record

Insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings [see Clinical Studies

Use listed on the medicine record

Cough, sneezing, runny nose, occasional headache, nausea, or weakness

Use listed on the medicine record

The symptomatic relief of cough

Use listed on the medicine record

The gradual bleaching of hyperpigmented skin conditions age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation

Use listed on the medicine record

Moderate-to-severe plaque psoriasis

Use listed on the medicine record

Acute myeloid leukemia (AML) as a component of a combination chemotherapy regimen

Use listed on the medicine record

FANAPT ® is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . FANAPT is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 )

Use listed on the medicine record

Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML) in chronic phase (1.1) Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy (1.2) Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) (1.3) Pediatric patients with newly diagnosed Philadelphia chromosome…

Use listed on the medicine record

Isoniazid tablets, USP are recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. Single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. Isoniazid tablets, USP are recommended as preventive therapy for the following groups, regardless of age.

Use listed on the medicine record

INSTRUCTIONS FOR USE 1. Cleanse and moisturize. 2. Apply the mask evenly to the face, avoiding eyes and mouth. 3. Let dry for 15 mins, then sleep. 4. Remove mask or rinse next morning.

Use listed on the medicine record

Community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms

Use listed on the medicine record

Pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Use listed on the medicine record

HIV-1 infection

Use listed on the medicine record

Metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy

Use listed on the medicine record

as Antacid • relieves • heartburn • sour stomach • acid indigestion • and upset stomach associated with these symptoms Uses as Saline Laxative • for relief of occasional constipation (irregularity) • this product generally produces bowel movement in 1/2 to 6 hours

Use listed on the medicine record

Cholestatic pruritus

Use listed on the medicine record

LIVTENCITY ® is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet [see Use in Specific Populations (8.4) and Clinical Studies (14) ] .

Use listed on the medicine record

Moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension

Use listed on the medicine record

Idiopathic heavy menstrual blood loss

Use listed on the medicine record

INDICATIONS For the temporary relief of diarrhea, gas, cramping, fatigue, minor joint pain or swelling, or occasional headache due to sensitivity to phenolic compounds found in foods or other products.*

Use listed on the medicine record

Pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Use listed on the medicine record

POLOCAINE (Mepivacaine HCl Injection, USP), is indicated for production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. The routes of administration and indicated concentrations for mepivacaine are: local infiltration 0.5% (via dilution) or 1 % peripheral nerve blocks 1% and 2% epidural block 1%, 1.5%, 2% caudal block 1%, 1.5%, 2% See DOSAGE AND ADMINISTRATION for additional information.

Use listed on the medicine record

Anxiety disorders or for the short-term relief of the symptoms of anxiety

Use listed on the medicine record

BIOCORNEUM ® can reduce the appearance of scars and is ideal for use on any intact skin surface, including skin that flexes (such as joints) and areas exposed to sun (such as the face and hands).